• Delivering innovative research
    to the therapy analysis market
  • Identifying and commercializing
    first-in-class innovation in early stage development
  • Thought provoking insights
    covering hot topics and key industry issues
  • Providing specialty research and data
    to the devices and diagnostics industries

Research Services

GBI Research provides intelligence from high-growth therapy areas and novel drug treatments to pioneering companies and their strategies

Research Services
Frontier Pharma
You are here:
Research Services >
Frontier Pharma

Frontier Pharma

GBI Research’s Frontier Pharma service has been developed by our industry experts specifically for healthcare professionals who are interested in innovative new product developments and licensing and co-development opportunities within a specific indication.

Frontier Pharma features:
  • Identifies unique, novel and potentially transformative (clinically and commercially) developmental programs across each indication covered

  • Provides a scientific and clinical perspective about the rationale, strength and weaknesses of novel products, based on available peer reviewed scientific literature

  • Assesses the trends in the licensing and co-development landscape with respect to drug properties and attributes (such as molecule type and mechanism of action)

  • Identifies novel products that have not been involved in licensing / co-development deals

  • Assists acquiring/out-licensing companies to benchmark expected upfront and total value of programs, and balance this against the projected risk of failure across different stages.

  • Focus on therapy areas with a high degree of R&D activity, innovation, strong competition and high deal activity

  • Entirely evidence and data-driven approach to ascertain the most interesting product developments in the pipeline

Analyst Views

28 Nov 16
Repurposing Type 2 Diabetes Mellitus Drugs for Alzheimer’s ....
In this Analyst View, Fiona Chisholm, Analyst for GBI Research, discusses the potential f.....
Read post
21 Nov 16
Urological Cancer Treatment Landscape to be Transformed by ....
In this Analyst View, Adam Bradbury, Associate Analyst for GBI Research, discuses current.....
Read post

White Papers

22 Nov 16
An Exploration of Novel and Repositioned Calcium Transport ....
This whitepaper discusses the increasing interest in using repositioned calcium transport....
Read post
14 Nov 16
The Emerging Field of Cannabinoid-Based Products....
This white paper discusses the current commercial landscape for cannabinoid-based product....
Read post

Press Releases

17 Oct 17
Industry pipeline for monoclonal antibodies encompasses ove....
The overall industry pipeline for monoclonal antibodies (mAbs) has reached a unprecedente.....
Read post
13 Oct 17
New Diabetes Therapeutics to Steal Ground from Insulin Ther....
The incidence of diabetes mellitus (DM), and most notably type 2 diabetes mellitus (T2DM).....
Read post